Metabolic cardiomyopathy is one of the most consequential cardiovascular complications of diabetes and obesity, quietly raising the risk of heart failure and malignant arrhythmias even before overt symptoms appear. Its core pathology involves a tangle of imbalanced myocardial energy metabolism, lipotoxic injury, and chronic low-grade inflammation that progressively remodels the heart muscle. While epidemiological studies have repeatedly associated diets rich in polyphenols with reduced cardiometabolic risk, the precise cellular mechanisms by which individual plant compounds defend heart cells under metabolic stress have remained murky. The new research set out to close that gap by asking how Sal B behaves when heart cells are bathed in dangerously high levels of glucose.

The team, based at institutions affiliated with Xiamen University and Xiamen ChangGung Hospital in China, worked with AC16 human cardiomyocytes, a widely used laboratory model of heart muscle cells. To mimic the metabolic environment of diabetes, the researchers exposed the cells to glucose concentrations ranging from a physiological 5.5 millimoles per liter up to a pathological 30 millimoles per liter. Cell death rose in a concentration-dependent manner, with the most severe damage at the highest glucose level, confirmed by light microscopy, viability assays, and TUNEL staining that flags fragmented DNA in dying cells.

Before testing protection, the researchers first established a safe working dose. They screened Sal B at concentrations from 10 to 320 micromoles per liter and settled on 40 micromoles per liter, the level that kept cell viability above 90 percent in the absence of stress. When cells were pretreated with Sal B for 24 hours before the high-glucose challenge, the results were striking. Viability recovered significantly, and the flood of proinflammatory cytokines that high glucose normally triggers, including interleukin-1 beta, interleukin-18, and tumor necrosis factor alpha, was substantially blunted in the culture supernatants.

The protective signature extended to oxidative stress, a parallel driver of metabolic heart injury. High glucose depleted superoxide dismutase, a key endogenous antioxidant enzyme, while elevating malondialdehyde, a marker of lipid peroxidation, and lactate dehydrogenase, a proxy for membrane damage. Sal B pretreatment reversed all three indicators and, as measured by flow cytometry with a fluorescent probe, reduced the intracellular accumulation of reactive oxygen species. TUNEL staining confirmed that fewer cells died when the polyphenol was on board, painting a picture of a compound that simultaneously damps oxidative and inflammatory damage.

The mechanistic heart of the study lies in pyroptosis, a form of regulated cell death executed by the gasdermin family of proteins. Under metabolic stress, the NLRP3 inflammasome assembles in cardiomyocytes, activating caspase-1, which in turn cleaves gasdermin D into its pore-forming N-terminal fragment. Those pores rupture the cell membrane and spill inflammatory contents into the surrounding tissue, amplifying injury. In the high-glucose model, the researchers observed the full pyroptotic cascade: elevated mRNA and protein levels of NLRP3, the adaptor protein ASC, cleaved caspase-1, and gasdermin D, together with the release of its active N-terminal fragment. Sal B pretreatment partially reversed every one of these molecular changes.

To identify the upstream switch controlling this cascade, the team turned to bioinformatics. Mining two public transcriptomic datasets from the Gene Expression Omnibus, one from muscle tissue of patients with diabetes and one from white adipose tissue and aortae of obese and atherosclerotic mice, they applied differential expression analysis, weighted gene co-expression network analysis, and intersection with a UniProt gene set for metabolic cardiomyopathy. A single candidate emerged from the overlap: MMP12, an elastin- and fibronectin-cleaving enzyme best known from atherosclerosis research but increasingly implicated in cardiac remodeling and fibrosis. Its expression correlated with inflammatory response and extracellular matrix remodeling signatures, and it discriminated disease status in the discovery cohort, though the authors caution that the small sample size makes the diagnostic performance provisional at best.

Molecular docking simulations then provided a structural rationale for how Sal B might engage MMP12. The polyphenol docked stably into the enzyme’s active cavity with a predicted binding free energy of minus 9.2 kilocalories per mole, well beyond the conventional threshold for favorable binding. Hydrogen bonds with residues Lys233 and Thr239 anchored the molecule, hydrophobic contacts with Phe114 and Leu117 stabilized the pose, and pi-pi stacking with Tyr242 in the S1′ specificity pocket added further grip, all in the vicinity of the catalytic zinc ion that drives the enzyme’s proteolytic activity.

The decisive evidence came from rescue experiments. The researchers engineered a plasmid that forced AC16 cells to overproduce MMP12, verified by Sanger sequencing and confirmed at both the mRNA and protein levels. When MMP12 was overexpressed, Sal B’s protection visibly weakened: TUNEL-positive cell death increased, the suppression of interleukin-1 beta, interleukin-18, and tumor necrosis factor alpha was partially undone, and the protein levels of NLRP3, ASC, cleaved caspase-1, and gasdermin D’s active fragment rebounded. In other words, flooding the cells with MMP12 partially bypassed the polyphenol’s brake on pyroptosis, placing MMP12 functionally upstream of the NLRP3 inflammasome in Sal B’s mechanism of action.

The authors are careful to frame the translational caveats. The 40 micromolar concentration used in the dish far exceeds what ordinary dietary intake achieves in human blood, given the low oral bioavailability of polyphenols, so the findings support mechanistic exploration rather than a dietary prescription. Nano-delivery systems such as liposomes and polymeric nanoparticles, along with the cumulative activity of Sal B’s in vivo metabolites, are proposed as routes to bridge that gap. The Sal B-MMP12 interaction itself rests on docking predictions and functional necessity rather than direct biophysical proof, and the high-glucose model may carry nonspecific osmotic effects that future mannitol control experiments should exclude. Non-canonical pyroptosis pathways and alternative inflammasomes such as AIM2 also remain untested. Even so, the study delivers a compelling preliminary map of how an edible plant polyphenol intercepts the MMP12-NLRP3-pyroptosis axis, offering a mechanistic foundation for functional food ingredients aimed at cardiometabolic health.

Subject of Research: Cytoprotective mechanisms of the plant polyphenol salvianolic acid B against high-glucose-induced cardiomyocyte pyroptosis via the MMP12–NLRP3 signaling axis

Article Title: Plant‐Derived Polyphenol Salvianolic Acid B Attenuates Cardiomyocyte Pyroptosis by Modulating the MMP12–NLRP3 Signaling Axis

Article References: Xie, Z., Yang, Z.-K., Zheng, L., Wu, P., Chen, S., Ye, X., & Gao, Y. (2026). Plant‐Derived Polyphenol Salvianolic Acid B Attenuates Cardiomyocyte Pyroptosis by Modulating the MMP12 – NLRP3 Signaling Axis. Food Science & Nutrition, 14(10), Article e72300. https://doi.org/10.1002/fsn3.72300

Image Credits: AI Generated

DOI: 10.1002/fsn3.72300

Keywords: salvianolic acid B, metabolic cardiomyopathy, pyroptosis, NLRP3 inflammasome, MMP12, cardiomyocytes, polyphenols, oxidative stress, diabetes, gasdermin D, molecular docking, functional foods